Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Motor Activity × Immunotherapy × Dermatologic × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 16 Neoplasm Metastasis 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Skin Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Autoimmune Diseases 1

Interventions

pembrolizumab 2 Nivolumab 2 Ipilimumab 2 Exercise 2 cemiplimab 1 avelumab 1 Psychology, Positive 1 Methods 1 Immunotherapy 1 Immune Checkpoint Inhibitors 1 Diet 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡